{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:25Z","timestamp":1789506625481,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006348","name":"Delaney AIDS Research Enterprise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpeds.2026.115201","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:33:28Z","timestamp":1781739208000},"page":"115201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pediatric Neuroinflammatory and Neuropsychiatric Syndromes Associated with Dupilumab Treatment for Atopic Dermatitis"],"prefix":"10.1016","volume":"297","author":[{"given":"Laurits","family":"Mathiesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0233-9361","authenticated-orcid":false,"given":"Keith P.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.115201_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17512433.2018.1449642","article-title":"Dupilumab for treatment of atopic dermatitis","volume":"11","author":"Seegr\u00e4ber","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2026.115201_bib2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/cpdd.798","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of dupilumab in healthy adult subjects","volume":"9","author":"Li","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jpeds.2026.115201_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","article-title":"Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis","volume":"84","author":"Halling","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2026.115201_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12016-022-08934-0","article-title":"Dupilumab-Associated adverse events during treatment of allergic diseases","volume":"62","author":"Kychygina","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jpeds.2026.115201_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/pde.14970","article-title":"A rare presentation of herpes simplex virus encephalitis occurring in a pediatric patient on dupilumab for atopic dermatitis","volume":"39","author":"Rao","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpeds.2026.115201_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14217","article-title":"Unveiling a suspected dupilumab-induced neuropathy in pediatric eosinophilic esophagitis","volume":"35","author":"Gagnon","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jpeds.2026.115201_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40257-025-00927-x","article-title":"Real-World evidence of tralokinumab effectiveness and safety: a systematic review and meta-analysis","volume":"26","author":"R\u00f8nnstad","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jpeds.2026.115201_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s13555-025-01357-7","article-title":"Lebrikizumab vs other systemic monotherapies for moderate-to-severe atopic dermatitis: network meta-analysis of efficacy","volume":"15","author":"Silverberg","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jpeds.2026.115201_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14740338.2024.2416921","article-title":"Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system","volume":"25","author":"Mao","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jpeds.2026.115201_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20091419","article-title":"Regulation of learning and memory by meningeal immunity: a key role for IL-4","volume":"207","author":"Derecki","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jpeds.2026.115201_bib11","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.4049\/jimmunol.1601546","article-title":"IL-13\u2013Mediated regulation of learning and memory","volume":"198","author":"Brombacher","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jpeds.2026.115201_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10753-023-01917-z","article-title":"Interleukin-4 modulates neuroinflammation by inducing phenotypic transformation of microglia following Subarachnoid hemorrhage","volume":"47","author":"Wang","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.jpeds.2026.115201_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/15459683211001026","article-title":"The role of the IL-4 signaling pathway in traumatic nerve injuries","volume":"35","author":"Daines","year":"2021","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.jpeds.2026.115201_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071485","article-title":"Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases","volume":"10","author":"Miyagawa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpeds.2026.115201_bib15","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.2147\/CCID.S574980","article-title":"Immunological antagonism between psoriasis and atopic dermatitis: pathways, clinical implications, and therapeutic perspectives","volume":"18","author":"Qin","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:32:39Z","timestamp":1789504359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347626002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"alternative-id":["S0022347626002295"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115201","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Neuroinflammatory and Neuropsychiatric Syndromes Associated with Dupilumab Treatment for Atopic Dermatitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115201"}}